LXRX FY 2022 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$704M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$139,000-53.4% YoY

Gross Profit

-$52M-37681.3% margin

Operating Income

-$101M-72489.2% margin

Net Income

-$102M-73341.0% margin

EPS (Diluted)

$-0.62

Cash Flow

Operating Cash Flow

-$89M

Free Cash Flow

-$90M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$194M

Total Liabilities

$77M

Stockholders' Equity

$117M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$139,000	$298,000	-53.4%
Gross Profit	-$52M	-$55M	+4.3%
Operating Income	-$101M	-$87M	-15.7%
Net Income	-$102M	-$88M	-16.2%